Alrawashdeh, Mohammad http://orcid.org/0000-0003-4657-0247
Rhee, Chanu
Klompas, Michael
Larochelle, Marc R.
Poland, Russell E.
Guy, Jeffrey S.
Kimmel, Simeon D.
Funding for this research was provided by:
Centers for Disease Control and Prevention (U54CK000484)
National Institute on Drug Abuse (1K23DA054363)
National Institute of Allergy and Infectious Diseases (5T32AI052074)
School of Medicine, Boston University (Career Investment Award)
Harvard Medical School (Departmental Award)
Article History
Received: 20 September 2022
Accepted: 26 January 2023
First Online: 14 February 2023
Declarations
:
: Dr. Larochelle reports consulting funds for research paid to his institution by OptumLabs. Dr. Kimmel reports receiving consulting fees from the Massachusetts Department of Public Health as well as the American Association of Addiction Psychiatry for trainings on harm reduction and substance use disorder treatment. None of the other authors have any conflicts of interest to disclose.
: This research was supported in part by HCA Healthcare. The views expressed in this publication represent those of the author(s) and do not necessarily represent the official views of HCA Healthcare or any of its affiliated entities.
Free to read: This content has been made available to all.